Literature DB >> 3023118

Control of HL-60 monocytic differentiation. Different pathways and uncoupled expression of differentiation markers.

A Yen, D Brown, J Fishbaugh.   

Abstract

Control of expression of the terminally differentiated phenotype was studied using the human promyelocytic leukemia cell line HL-60. Three known inducers of HL-60 monocytic differentiation were compared: 1,25-dihydroxy vitamin D3, tetradecanoylphorbol acetate (TPA), and sodium butyrate. At concentrations where all three inducers resulted in similar courses of G1/0-specific growth arrest, the kinetics of appearance of certain differentiation markers typically characteristic of mature monocytic cells was determined. The markers were inducible oxidative metabolism, non-specific esterase activity, and the cell surface determinants Mo1, My4, and Mo2. The results indicate that: Regulation of the expression of these markers during induced monocytic differentiation is not controlled in common. The three monocytic inducers do not induce the same metabolic cascade leading to differentiation. Similar states of differentiation could thus be reached by different pathways apparently due to the fact that control of expression of different differentiation markers was not tightly coupled.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3023118     DOI: 10.1016/0014-4827(87)90432-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  1,25-Dihydroxy vitamin D2 induces leukemia cell differentiation.

Authors:  A Yen; J Blue; M Forbes
Journal:  In Vitro Cell Dev Biol       Date:  1991-07

2.  Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes.

Authors:  R Heimer; A Van Andel; G P Wormser; M L Wilson
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

3.  DMSO, sodium butyrate, and TPA induce hypophosphorylation of RB with HL-60 cell differentiation.

Authors:  A Yen; S Varvayanis
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-03       Impact factor: 2.416

4.  Inhibiting the platelet derived growth factor receptor increases signs of retinoic acid syndrome in myeloid differentiated HL-60 cells.

Authors:  Gudrun Reiterer; Rodica P Bunaciu; James L Smith; Andrew Yen
Journal:  FEBS Lett       Date:  2008-06-20       Impact factor: 4.124

5.  Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells.

Authors:  Miaoqing Shen; Andrew Yen
Journal:  Oncology       Date:  2009-01-06       Impact factor: 2.935

6.  Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.

Authors:  J Schwaller; H P Koeffler; G Niklaus; P Loetscher; S Nagel; M F Fey; A Tobler
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

7.  NAD metabolites interfere with proliferation and functional properties of THP-1 cells.

Authors:  Katharina Petin; Ronald Weiss; Gerd Müller; Antje Garten; Anja Grahnert; Ulrich Sack; Sunna Hauschildt
Journal:  Innate Immun       Date:  2019-05-03       Impact factor: 2.680

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.